Trial intelligence / Profile preview

Intrathecal dexmedetomidine-ropivacaine vs fentanyl-ropivacaine vs ropivacaine alone for spinal anesthesia in lower limb orthopedic surgery

IRCT20260827070816N1Phase 4Recruiting

Sponsor
Jahrom University of Medical Sciences
Start
Nov 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in intrathecal anesthesia comparing Ropivacaine + dexmedetomidine, Ropivacaine + fentanyl and Ropivacaine alone (3 arms). Primary endpoint: Time to onset of sensory-motor block. Started Nov 2026; status: recruiting.

02

Drugs

dexmedetomidinefentanylropivacaine
03

Conditions

intrathecal anesthesia

Beyond the preview

Go deeper on IRCT20260827070816N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260827070816N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call